Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
iShares US Real Estate ETF
IYR
|
+$1B |
| 2 |
Tesla
TSLA
|
+$697M |
| 3 |
Microsoft
MSFT
|
+$447M |
| 4 |
Accenture
ACN
|
+$439M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$421M |
Top Sells
| 1 |
CRH
CRH
|
+$2.27B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.01B |
| 3 |
Texas Instruments
TXN
|
+$1.97B |
| 4 |
Starbucks
SBUX
|
+$1.61B |
| 5 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$1.07B |
Sector Composition
| 1 | Technology | 32.41% |
| 2 | Financials | 11.84% |
| 3 | Consumer Discretionary | 10.72% |
| 4 | Healthcare | 9.02% |
| 5 | Communication Services | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDMO
2301
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.53M | ﹤0.01% |
134,598
+66,653
| +98% | +$759K |
|
2302
Maravai LifeSciences
MRVI
$394M
| $1.53M | ﹤0.01% |
184,189
+143,184
| +349% | +$1.19M |
|
2303
Blend Labs
BLND
$1.1B
| $1.53M | ﹤0.01% |
407,774
+295,460
| +263% | +$1.11M |
|
2304
Methode Electronics
MEI
$282M
| $1.53M | ﹤0.01% |
127,917
+67,656
| +112% | +$809K |
|
2305
American Express Global Business Travel
GBTG
$4.29B
| $1.53M | ﹤0.01% |
198,673
+155,696
| +362% | +$1.2M |
|
2306
Universal Insurance Holdings
UVE
$694M
| $1.53M | ﹤0.01% |
68,969
+28,278
| +69% | +$626K |
|
|
GMRE
2307
Global Medical REIT
GMRE
$518M
| $1.53M | ﹤0.01% |
154,051
+71,704
| +87% | +$711K |
|
|
HUT
2308
Hut 8
HUT
$3.6B
| $1.53M | ﹤0.01% |
124,527
+31,632
| +34% | +$388K |
|
2309
Perspective Therapeutics
CATX
$270M
| $1.52M | ﹤0.01% |
114,075
+97,493
| +588% | +$1.3M |
|
2310
National Vision
EYE
$1.87B
| $1.52M | ﹤0.01% |
139,302
+10,373
| +8% | +$113K |
|
2311
Evolus
EOLS
$428M
| $1.52M | ﹤0.01% |
93,662
+68,213
| +268% | +$1.11M |
|
2312
Brighthouse Financial
BHF
$2.65B
| $1.51M | ﹤0.01% |
33,429
-33,503
| -50% | -$1.51M |
|
2313
NB Bancorp
NBBK
$734M
| $1.51M | ﹤0.01% |
81,114
+34,235
| +73% | +$636K |
|
2314
ProShares UltraPro Short QQQ
SQQQ
$2.15B
| $1.5M | ﹤0.01% |
40,679
+24,900
| +158% | +$920K |
|
2315
iShares ESG Aware MSCI USA ETF
ESGU
$14.5B
| $1.5M | ﹤0.01% |
11,899
-3,700
| -24% | -$467K |
|
|
AMED
2316
DELISTED
Amedisys
AMED
| $1.5M | ﹤0.01% |
15,529
+5,142
| +50% | +$497K |
|
2317
Alpha and Omega Semiconductor
AOSL
$876M
| $1.5M | ﹤0.01% |
40,359
+31,725
| +367% | +$1.18M |
|
2318
Tompkins Financial
TMP
$982M
| $1.5M | ﹤0.01% |
25,878
+13,878
| +116% | +$802K |
|
2319
Douglas Dynamics
PLOW
$742M
| $1.49M | ﹤0.01% |
54,116
+30,795
| +132% | +$850K |
|
2320
FTAI Infrastructure
FIP
$551M
| $1.49M | ﹤0.01% |
159,387
+117,863
| +284% | +$1.1M |
|
2321
Castle Biosciences
CSTL
$649M
| $1.49M | ﹤0.01% |
52,301
+39,567
| +311% | +$1.13M |
|
2322
Vanguard Short-Term Corporate Bond ETF
VCSH
$39.5B
| $1.49M | ﹤0.01% |
18,760
| – | – |
|
2323
AnaptysBio
ANAB
$533M
| $1.49M | ﹤0.01% |
44,300
+23,926
| +117% | +$803K |
|
2324
Choice Hotels
CHH
$5.11B
| $1.49M | ﹤0.01% |
11,409
-19,055
| -63% | -$2.48M |
|
2325
Fate Therapeutics
FATE
$113M
| $1.49M | ﹤0.01% |
424,277
+301,389
| +245% | +$1.05M |
|